By The Associated Press The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to grant Novavax full approval – without restrictions -- by its April 1 target ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

WASHINGTON — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions. Novavax makes the nation’s only traditional ...

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...

Healthy younger adults and children will no longer be automatically approved for annual COVID-19 vaccines under a new policy ...

That's the same limit the FDA set in licensing another COVID-19 vaccine option from competitor Novavax. Those restrictions are ... measures - than the original shot, the company said.

The vaccine is expected to remain available for anyone who is at least 65 or who has a medical condition, leaving many ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...